Nevirapine (Standard)
Based on 1 Customer Validation
Nevirapine (Standard) is the analytical standard of Nevirapine. This product is intended for research and analytical applications. Nevirapine is a non-nucleoside inhibitor of HIV-1 reverse transcriptase used to treat and prevent HIV/AIDS; with a Ki of 270 μM.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.49%
- CAS. Nr.: 129618-40-2
- Formel: C15H14N4O
- Molecular Weight:266.30
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-17413R
Zidovudine (Standard)Standard of Zidovudine -
HY-10570
NevirapineHIV-1 Reverse Transcriptase Inhibitor -
HY-17427
EmtricitabineNRT Inhibitor -
HY-B0250
LamivudineReverse Transcriptase Inhibitor -
HY-17392
ZalcitabineReverse Transcriptase Inhibitor -
HY-10572
EfavirenzHIV NNRTI -
HY-13910
TenofovirNucleotide Reverse Transcriptase Inhibitor -
HY-B0249
DidanosineAnti-HIV Agent -
HY-B0250R
Lamivudine (Standard)Reverse Transcriptase Inhibitor -
HY-14266
DapivirineNRTI -
HY-10574
RilpivirineNNRTI -
HY-14267
LersivirineNNRTI
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 129618-40-2
-
Appearance Solid
-
Molecular Weight 266.30
-
Formel C15H14N4O
-
Color White to off-white
-
SMILES
O=C1C2=C(N=CC=C2)N(C3CC3)C4=NC=CC(C)=C4N1
-
Synonyms
BI-RG 587 (Standard); NSC 641530 (Standard); NVP (Standard)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Erickson DA, et al. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitornevirapine by human hepatic cytochromes P-450. Drug Metab Dispos. 1999 Dec;27(12):1488-95. [Content Brief]
[2]. Dong JJ, et al. In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma. Mol Cell Endocrinol. 2013 May 6;370(1-2):113-8. [Content Brief]
[3]. Merluzzi VJ, et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science. 1990 Dec 7;250(4986):1411-3. [Content Brief]
[4]. Riska PS, et al. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Drug Metab Dispos. 1999 Dec;27(12):1434-47. [Content Brief]
[5]. Onasanwo SA, et al. Evaluation of anti-ulcerogenic and ulcer-healing activities of nevirapine in rats. Afr J Med Med Sci. 2015 Sep;44(3):251-9. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Nevirapine (Standard) Related Classifications
HY-10570R Related Classifications
Powered by Bioz